I agree. We are all burnt here. Whether losses are crystalised or on paper, the reality is the value of the holdings have been desimated.
As you know, I have recognised the parallels particularly with EHR and PAX. I am not surprised at all that EHR's SP is now down to the same levels as PAX.
Until I see PAX with an executed PPA and project funding, I cannot see the differences, particularly with such a heavy focus and mucking about with corporate finance. Having said that, Indonesia does offer more attractive tariff rates than that offered in Argentina and Daima Prima capex is relatively low - two factors which attracted me. So as it stands, PAX IMHO offers the better potential at this very point in time than EHR or HRL. Again, just waiting for this elusive PPA.
All the best to you with EHR. (I have seen the suffering going on in that forum so would be good to see something turned around there).
PT
PAX Price at posting:
0.3¢ Sentiment: None Disclosure: Held
